CALLEX MEDICAMENTOS S. DE RL DE CV — Cyclophosphamide Importer Profile
Pharmaceutical Importer · #15 buyer for Cyclophosphamide · $107.3K import value · 23 shipments · MEXICO · DGFT Verified
CALLEX MEDICAMENTOS S. DE RL DE CV is the #15 importer of Cyclophosphamide from India with $107.3K in import value and 23 verified shipments. CALLEX MEDICAMENTOS S. DE RL DE CV holds a 0.5% market share in Cyclophosphamide imports based in MEXICO. The company sources from 1 verified supplier across 3 formulations shipped to 1 country.
CALLEX MEDICAMENTOS S. DE RL DE CV — Cyclophosphamide Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Cyclophosphamide to CALLEX MEDICAMENTOS S. DE RL DE CV?
Verified from 23 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| GLS PHARMA LIMITED | $107.3K | 23 | 100.0% |
CALLEX MEDICAMENTOS S. DE RL DE CV sources Cyclophosphamide from 1 verified Indian supplier based on 23 customs records. The primary supplier is GLS PHARMA LIMITED accounting for 100.0% of imports.
How Does CALLEX MEDICAMENTOS S. DE RL DE CV Compare to Nearest Cyclophosphamide Importers?
Buyers ranked immediately above and below #15 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 6 | AUROMEDICS PHARMA, LLC,., | UNITED STATES | $100.0K | 2 | $50.0K |
| 11 | XXNEAXXEU XXMITXX | UNITED STATES | $100.0K | 2 | $50.0K |
| 15 | CALLEX MEDICAMENTOS S. DE RL DE CV ★ | MEXICO | $88.1K | 19 | $4.6K |
CALLEX MEDICAMENTOS S. DE RL DE CV ranks #15 among 518 Cyclophosphamide importers from India. Average shipment value of $4.6K compared to the market average of $7.2K. The closest competitors by value are AUROMEDICS PHARMA, LLC,., and XXNEAXXEU XXMITXX.
Where Does CALLEX MEDICAMENTOS S. DE RL DE CV Import Cyclophosphamide To?
Destination countries from 23 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| MEXICO | $107.3K | 23 | 100.0% |
CALLEX MEDICAMENTOS S. DE RL DE CV imports Cyclophosphamide to 1 country. The primary destination is MEXICO receiving 100.0% of shipments worth $107.3K.
What Cyclophosphamide Formulations Does CALLEX MEDICAMENTOS S. DE RL DE CV Import?
| Formulation | Value | Shipments |
|---|---|---|
| PONFECYC 200MG INJECTION (CYCLOPHOSPHAMIDE FOR INJECTION 200MG/VIAL)VLS | $52.4K | 11 |
| PONFECYC 500MG INJECTION (CYCLOPHOSPHAMIDE FOR INJECTION 500MG/VIAL)VLS | $35.7K | 8 |
| PONFECYC 500MG INJECTION CYCLOPHOSPHAMIDE FOR INJECTION 500MG/VIAL | $19.2K | 4 |
CALLEX MEDICAMENTOS S. DE RL DE CV imports 3 distinct Cyclophosphamide formulations from India. The top formulation is PONFECYC 200MG INJECTION (CYCLOPHOSPHAMIDE FOR INJECTION 200 with 11 shipments worth $52.4K.
Regulatory Requirements: Importing Cyclophosphamide into Mexico
What CALLEX MEDICAMENTOS S. DE RL DE CV and other importers must comply with to import Cyclophosphamide from India
Regulatory Authority
Federal Commission for the Protection against Sanitary Risk (COFEPRIS)
Approval Process for Generic Cyclophosphamide
Generic drug registration under Mexican health law. Requires bioequivalence study and GMP compliance. NOM standards apply.
Typical timeline: 12–18 months
GMP Requirements
Mexican GMP (NOM-059-SSA1); COFEPRIS overseas inspection or PIC/S certificate
Import Licence & Documentation
Sanitary Import Permit from COFEPRIS; import licence via Mexican customs (SAT)
Labeling & Packaging
Spanish language labeling mandatory; Mexican Official Norms (NOM) compliance
Note: Mexico requires GMP compliance per NOM-059. COFEPRIS participates in PIC/S, easing recognition of PIC/S certificates from Indian authorities.
Regulatory information is provided for general reference based on publicly available COFEPRIS guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with COFEPRIS or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Cyclophosphamide from India and How Much Does CALLEX MEDICAMENTOS S. DE RL DE CV Import?
India exported $3.7M worth of Cyclophosphamide through 2,113 shipments from 259 suppliers to 114 countries, serving 518 buyers globally. CALLEX MEDICAMENTOS S. DE RL DE CV imports $107.3K of this total, accounting for 0.5% of India's Cyclophosphamide exports with 23 shipments from MEXICO. This is verified from 23 customs shipment records covering 3 distinct formulations.
What Is the Average Order Value for CALLEX MEDICAMENTOS S. DE RL DE CV's Cyclophosphamide Imports?
CALLEX MEDICAMENTOS S. DE RL DE CV's average Cyclophosphamide order value is $4.7K per consignment, based on 23 shipments totaling $107.3K. CALLEX MEDICAMENTOS S. DE RL DE CV is based in MEXICO and ranks #15 among all Cyclophosphamide importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Cyclophosphamide to CALLEX MEDICAMENTOS S. DE RL DE CV?
CALLEX MEDICAMENTOS S. DE RL DE CV sources Cyclophosphamide from 1 verified Indian supplier: GLS PHARMA LIMITED ($107.3K, 100.0%). This is based on 23 customs records.
How Does CALLEX MEDICAMENTOS S. DE RL DE CV Compare to Other Cyclophosphamide Importers?
CALLEX MEDICAMENTOS S. DE RL DE CV ranks #15 among 518 Cyclophosphamide importers from India with a 0.5% market share. The top 3 importers are EUGIA US LLC ($550.0K), CIPLA USA INC UPS SUPPLY CHAIN SOLU ($500.0K), J. KNIPPER & COMPANY ($467.5K). CALLEX MEDICAMENTOS S. DE RL DE CV processed 23 shipments from MEXICO.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Cyclophosphamide — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Cyclophosphamide shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: CALLEX MEDICAMENTOS S. DE RL DE CV matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as CALLEX MEDICAMENTOS S. DE RL DE CV's capped import value divided by total capped export value for Cyclophosphamide across all Indian exporters.
- 5.Verified Records: This page is backed by 23 individual customs records matching CALLEX MEDICAMENTOS S. DE RL DE CV importing Cyclophosphamide, covering 3 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 114+ countries, 518+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Cyclophosphamide Import Data for CALLEX MEDICAMENTOS S. DE RL DE CV
Access order-level details, pricing data, supplier connections, and competitive analysis for CALLEX MEDICAMENTOS S. DE RL DE CV's Cyclophosphamide imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
CALLEX MEDICAMENTOS S. DE RL DE CV
Company Profile
Multiple products · $0 total trade · Multiple categories
CALLEX MEDICAMENTOS S. DE RL DE CV × Cyclophosphamide
Verified from customs records
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for CALLEX MEDICAMENTOS S. DE RL DE CV.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Cyclophosphamide. For current order-level data, contact TransData Nexus.